Image

Global Bioinformatics Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Bioinformatics Market, By Product Type (Sequencing Platforms, Knowledge Management Tools, Bioinformatics Software), Services (Data Analysis, Sequencing, Database integration, Others), Application (Preventive Medicine, Molecular Medicine, Genomics, Drug Development, Transcriptomics, Others), End User (Medical Biotechnology, Academics, Animal  Biotechnology, Agricultural Biotechnology, Environmental Biotechnology, Forensic Biotechnology) – Industry Trends and Forecast to 2029

Bioinformatics Market

Market Analysis and Size

Surging cases of various infectious diseases which results in growing bioinformatics prevalence is estimated to drive the market’s growth across the globe. The bioinformatics market is largely influenced by surging focus of key players towards technological advances in the field of molecular diagnostics and indulging towards collaboration and partnerships with other organizations. Owing to the presence of various growth determinants the market is being propelled forward and is projected to show substantial growth over the forecasted period.

  • Global Bioinformatics Market was valued at USD 10.7 billion in 2021 and is expected to reach USD 34.35 billion by 2029, registering a CAGR of 15.7% during the forecast period of 2022-2029. The “Transcriptomics” accounts for the largest application segment in the bioinformatics market within the forecasted period owing to the surge in preference in companion diagnostics and personalized medicines. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Bioinformatics is a field of science that combines biology and information technology to integrate biological data with systems for data storage, dissemination, and analysis to assist a variety of scientific endeavors, including biomedicine. Data management, database building, data warehousing, data mining, and other software technologies are used in bioinformatics.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

By Product Type (Sequencing Platforms, Knowledge Management Tools, Bioinformatics Software), Services (Data Analysis, Sequencing, Database integration, Others), Application (Preventive Medicine, Molecular Medicine, Genomics, Drug Development, Transcriptomics, Others), End User (Medical Biotechnology, Academics, Animal  Biotechnology, Agricultural Biotechnology, Environmental Biotechnology, Forensic Biotechnology)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa

Market Players Covered

Thermo Fisher Scientific, (US), Eurofins Scientific (Luxembourg), QIAGEN (Netherlands), Agilent Technologies, Inc. (US), Illumina, Inc. (US), Waters Corporation (US), DNASTAR (US), NeoGenomics Laboratories (US), Perkin Elmer, Inc. (US), GENEWIZ (US) BGI (China), Fios Genomics (UK), Partek Incorporated (US), SOPHiA Genetics (Switzerland), Source BioScience (UK), and Biomax Informatics AG (Germany)

 

Bioinformatics Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

  • Growing Need for Bioinformatics

The rise in need for integrated data coupled with the surge in demand for nucleic acid and protein sequencing are the most significant factors driving the growth for this market. The increase in applications of proteomics and genomics are also expected to accelerate the overall growth of the market.

Growing Investments and Advancements

The drug discovery and development and initiatives from government and private organizations will further expand the bioinformatics market's growth rate in the future. Moreover, the increased investments for research and development in the field of bioinformatics from global players are estimated to generate lucrative opportunities for the market within the forecasted period.

Furthermore, the large sequencing projects and expanding healthcare sector are also expected to fuel market growth. The reduction in sequencing cost along with the rising applications of bioinformatics will cushion the growth of the market.

Restraints/Challenges

  • High Costs of Equipment

The bioinformatics equipment generally need advanced computer expertise as they lack a suitable user-friendly interface. They are also have advanced features and functionalities, resulting in high costs, which is expected to obstruct market growth.

  • Dearth of Professionals

Also, the field of bioinformatics requires skilled professionals. The dearth of skilled professionals are projected to challenge the bioinformatics market in the forecast period of 2022-2029.

This bioinformatics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bioinformatics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post Covid-19 Impact on Bioinformatics Market

Healthcare industry was largely impacted by the outbreak of COVID-19. The bioinformatics market was however positively affected due to the pandemic, as one of the key priority is basically to investigate and understand ways to stop the virus's spread. Bioinformatics provides critical assistance to various fields in scientific research.

SARS-CoV-2 genomes are generally investigated using next-generation sequencing, which provides basic information about the virus. For calculating such data and enhancing understanding of SARS-CoV-2, bioinformatics pipelines and biological and host-virus interaction databases are crucial tools. As a result, several investigations are being conducted to better comprehend the virus's genetic combination; these studies are aided by bioinformatics. Outsourcing of bioinformatics has risen during the epidemic in this context. Scientists have been able to unearth several information of SARS-CoV-2, spanning from its identification to its genesis (including its functioning and propagation), because of developed and enhanced bioinformatics capabilities.

Recent Developments

  • In March 2021, Agilent Technologies Inc., announced the release of SureSelect Human All Exon V8 – a new exome design that includes complete information and up-to-date coverage of protein-coding areas from RefSeq, CCDS, and GENCODE. It also includes the TERT promoter and difficult-to-capture exons not found in other exomes. Routine exome sequencing (Exome v8), clinical research sequencing (v8 Clinical Plus), and translational research (v8 UTR Plus) are also accessible in the new design, providing for content flexibility to match costumer’s demands.

Global Bioinformatics Market Scope

The bioinformatics market is segmented on the basis of product type, services, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Sequencing Platforms
  • Knowledge Management Tools
  • Bioinformatics Software

On the basis of product type, the bioinformatics market is segmented into sequencing platforms, knowledge management tools and bioinformatics software. Sequencing platforms is sub-segmented into sequence analysis platforms, sequence alignment platforms, sequence manipulation platforms, structural analysis platforms and others.  Knowledge management tools is sub-segmented into generalized knowledge management tools and specialized knowledge management tools.

Services

  • Data Analysis
  • Sequencing
  • Database integration
  • Others

On the basis of services, the bioinformatics market is segmented into data analysis, sequencing, database integration and others.

Application

  • Preventive Medicine
  • Molecular Medicine
  • Genomics
  • Drug Development
  • Transcriptomics
  • Others

On the basis of application, the bioinformatics market is segmented into preventive medicine, molecular medicine, genomics, drug development, transcriptomics and others. Transcriptomics is projected to register the highest growth owing to the surge in preference in companion diagnostics and personalized medicines.

End User

  • Medical Biotechnology
  • Academics
  • Animal Biotechnology
  • Agricultural Biotechnology
  • Environmental Biotechnology
  • Forensic Biotechnology

On the basis of end user, the bioinformatics market is bifurcated into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology and forensic biotechnology.

Bioinformatics Market Regional Analysis/Insights

The bioinformatics market is analyzed and market size insights and trends are provided by country, product type, services, application and end user as referenced above.

The countries covered in the bioinformatics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the bioinformatics market because of the rising applications of bioinformatics, increasing number of collaborations between companies and research institutes, increase in the need for integrated data and rise in the growth in proteomics and genomics within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increasing presence of skilled and trained bioinformaticians within the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The bioinformatics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for bioinformatics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the bioinformatics market. The data is available for historic period 2010-2020.

Competitive Landscape and Bioinformatics Market Share Analysis

The bioinformatics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to bioinformatics market.

Some of the major players operating in the bioinformatics market are Thermo Fisher Scientific, (US), Eurofins Scientific (Luxembourg), QIAGEN (Netherlands), Agilent Technologies, Inc. (US), Illumina, Inc. (US), Waters Corporation (US), DNASTAR (US), NeoGenomics Laboratories (US), Perkin Elmer, Inc. (US), GENEWIZ (US) BGI (China), Fios Genomics (UK), Partek Incorporated (US), SOPHiA Genetics (Switzerland), Source BioScience (UK), and Biomax Informatics AG (Germany) among others.

Research Methodology : Global Bioinformatics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available : Global Bioinformatics Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The Bioinformatics Market is Expected to Show a Value of USD 10.7 Billion in 2021.
The Bioinformatics Market is Estimated to Register a CAGR of 15.7% within the Forecast Period.
The factor such as rise in need for integrated data, the surge in demand for nucleic acid and protein sequencing coupled with increased investments for research and development in the field of bioinformatics from global players are the major drivers for the market.
The Major Companies Operating in the Bioinformatics Market are Thermo Fisher Scientific, (US), Eurofins Scientific (Luxembourg), QIAGEN (Netherlands), Agilent Technologies, Inc. (US), Illumina, Inc. (US), NeoGenomics Laboratories (US) and Perkin Elmer, Inc. (US).
The Countries Covered in the Bioinformatics Market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.